2024年7月13日 · Scemblix (asciminib) is commonly used for treating certain kinds of Philadelphia chromosome-positive chronic myeloid leukemia (PH+ CML) in adults.

Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs). (1) This indication is...

2025年3月13日 · Asciminib is used in adults to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (CML). Asciminib is usually given after other treatments have failed. Asciminib may also be used for …

2025年3月1日 · Asciminib is used to treat Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP) in patients who are newly diagnosed or who have received previous treatment. It is also used to treat Ph+ CML in CP with the T315I mutation.

2024年10月31日 · Scemblix (asciminib) is an oral kinase inhibitor that may be used to treat adults with a type of cancer called chronic myelogenous leukemia (CML; also called chronic myeloid leukemia). It is approved to treat: Ph+ CML in CP with the T315I mutation. This mutation can cause resistance to some medications.

Learn more about SCEMBLIX® (asciminib) tablets, a treatment for adults with Ph+ CML in chronic phase. See full Safety & Prescribing Information.

Asciminib, sold under the brand name Scemblix, is a medication used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). [5] [7] [8] Asciminib is a protein kinase inhibitor. [5] The most common adverse reactions include upper respiratory tract infections, musculoskeletal pain, fatigue, nausea, rash, and diarrhea. [7]

2021年10月29日 · SCEMBLIX® (asciminib) tablets, for oral ... SCEMBLIX is indicated for the treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). This indication is ...

2024年11月13日 · Scemblix (asciminib) is a kinase inhibitor indicated for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs) and Ph+ CML in CP with the T315I mutation. What Are Side Effects of Scemblix?

Asciminib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells) as a first treatment and in people who can no longer benefit from other leukemia medications. Asciminib is in a class of medications called kinase inhibitors.